Is MANGOCEUTICALS, INC. (MGRX) Halal?

NASDAQ Healthcare United States $8M
✓ HALAL
Confidence: 83/100
MANGOCEUTICALS, INC. (MGRX) is Halal under all 5 major Shariah screening standards. With a debt ratio of just 3.5% against the AAOIFI threshold of 30%, MANGOCEUTICALS, INC. comfortably passes the key financial ratio tests. The company operates in the Healthcare sector (Health Information Services), which is not a prohibited industry under Islamic finance principles.

Shariah Screening — 5 Standards

Based on financial data from December 2024

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 3.5%
/ 30%
1.0%
/ 30%
0.0%
/ 30%
0.0%
/ 5%
✓ HALAL
DJIM 3.5%
/ 33%
1.0%
/ 33%
0.0%
/ 33%
0.0%
/ 5%
✓ HALAL
MSCI 1.4%
/ 33%
0.4%
/ 33%
0.0%
/ 33%
0.0%
/ 5%
✓ HALAL
S&P 3.5%
/ 33%
1.0%
/ 33%
0.0%
/ 33%
0.0%
/ 5%
✓ HALAL
FTSE 1.4%
/ 33%
0.4%
/ 33%
0.0%
/ 50%
0.0%
/ 5%
✓ HALAL

Financial Highlights

EPS
$-2.72
P/B Ratio
0.4
EV/EBITDA
-0.4
EV: $6M
Revenue
$615,873
Growth: -36.8%
Beta
2.3
High volatility
Current Ratio
0.7

Profitability

Gross Margin 60.6%
Operating Margin -8913.9%
Net Margin 0.0%
Return on Equity (ROE) -136.2%
Return on Assets (ROA) -73.8%

Cash Flow & Balance Sheet

Operating Cash Flow-$5M
Free Cash Flow-$5M
Total Debt$214,962
Debt-to-Equity0.7
Current Ratio0.7
Total Assets$15M

Price & Trading

Last Close$0.37
50-Day MA$0.42
200-Day MA$1.38
Avg Volume7.5M
Beta2.3
52-Week Range
$0.16
$2.88

About MANGOCEUTICALS, INC. (MGRX)

CEO
Mr. Jacob D. Cohen
Employees
3
Sector
Healthcare
Industry
Health Information Services
Country
United States
Exchange
NASDAQ
Market Cap
$8M
Currency
USD

Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone replacement therapy under the Prime brand; and access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations. The company markets and sells its products online through its website www.MangoRX.com. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is MANGOCEUTICALS, INC. (MGRX) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), MANGOCEUTICALS, INC. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is MANGOCEUTICALS, INC.'s debt ratio?

MANGOCEUTICALS, INC.'s debt ratio is 3.5% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 1.4%.

What are MANGOCEUTICALS, INC.'s key financial metrics?

MANGOCEUTICALS, INC. has a market capitalization of $8M, and revenue of $615,873. Return on equity stands at -136.2%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.